Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Haney

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|October 31, 2017
High-Content Screening Approaches That Minimize Confounding Factors in RNAi, CRISPR, and Small Molecule ScreeningSteven A Haney
Expert Opinion on Therapeutic Targets|November 22, 2007
Expanding the repertoire of RNA interference screens for developing new anticancer drug targetsSteven A Haney
Expert Opinion on Drug Discovery|March 20, 2013
Anticancer drug development incorporating high-content screening and RNAi: synergistic approaches to improve target identification and validationSteven A Haney
Idrugs : the Investigational Drugs Journal|December 2, 2005
RNAi and high-content screening in target identification and validationSteven A Haney
Journal of Biomolecular Screening|March 22, 2014
Rapid Assessment and Visualization of Normality in High-Content and Other Cell-Level Data and Its Impact on the Interpretation of Experimental ResultsSteven A Haney
Assay and Drug Development Technologies|August 16, 2018
Perspective: SBI<sup>2</sup> at Its Fifth Annual MeetingSteven A Haney
Pharmacogenomics|August 25, 2007
Increasing the robustness and validity of RNAi screensSteven A Haney
Assay and Drug Development Technologies|February 20, 2014
Interview with Steven A. Haney, PhDSteven A Haney, Vicki Glaser
Drug Discovery Today|September 26, 2006
High-content screening moves to the front of the lineSteven A Haney, Peter LaPan, Jing Pan, et al.
BMC Cell Biology|August 5, 2008
Single cell cytometry of protein function in RNAi treated cells and in native populationsPeter LaPan, Jing Zhang, Jing Pan, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|October 31, 2017
High-Content Screening Approaches That Minimize Confounding Factors in RNAi, CRISPR, and Small Molecule ScreeningSteven A Haney
Expert Opinion on Therapeutic Targets|November 22, 2007
Expanding the repertoire of RNA interference screens for developing new anticancer drug targetsSteven A Haney
Expert Opinion on Drug Discovery|March 20, 2013
Anticancer drug development incorporating high-content screening and RNAi: synergistic approaches to improve target identification and validationSteven A Haney
Idrugs : the Investigational Drugs Journal|December 2, 2005
RNAi and high-content screening in target identification and validationSteven A Haney
Journal of Biomolecular Screening|March 22, 2014
Rapid Assessment and Visualization of Normality in High-Content and Other Cell-Level Data and Its Impact on the Interpretation of Experimental ResultsSteven A Haney
Assay and Drug Development Technologies|August 16, 2018
Perspective: SBI<sup>2</sup> at Its Fifth Annual MeetingSteven A Haney
Pharmacogenomics|August 25, 2007
Increasing the robustness and validity of RNAi screensSteven A Haney
Assay and Drug Development Technologies|February 20, 2014
Interview with Steven A. Haney, PhDSteven A Haney, Vicki Glaser
Drug Discovery Today|September 26, 2006
High-content screening moves to the front of the lineSteven A Haney, Peter LaPan, Jing Pan, et al.
BMC Cell Biology|August 5, 2008
Single cell cytometry of protein function in RNAi treated cells and in native populationsPeter LaPan, Jing Zhang, Jing Pan, et al.
Pageof 2